Patient Preferences and Health State Utilities Associated with Mealtime Insulin Concentrations Among Patients with Diabetes in Italy-Reference-Cited by-同舟云学术

Patient Preferences and Health State Utilities Associated with Mealtime Insulin Concentrations Among Patients with Diabetes in Italy

Published:2019-11-23 Issue:1 Volume:11 Page:319-330
ISSN:1869-6953
Container-title:Diabetes Therapy
language:en
Short-container-title:Diabetes Ther

Author:

Matza Louis S.^ORCID,Osumili Beatrice,Stewart Katie D.,Perez-Nieves Magaly,Jordan Jessica,Biricolti Giovanni,Romoli Ester,Losi Serena,Del Santo Silvia,Spaepen Erik,Parola Gordon,Karn Hayley,Boye Kristina S.

Funder

Eli Lilly and Company

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13300-019-00718-8.pdf

Reference42 articles.

1. Brennan VK, Dixon S. Incorporating process utility into quality adjusted life years: a systematic review of empirical studies. Pharmacoeconomics. 2013;31(8):677–91.

2. Higgins A, Barnett J, Meads C, Singh J, Longworth L. Does convenience matter in health care delivery? A systematic review of convenience-based aspects of process utility. Val Health. 2014;17(8):877–87.

3. Gelhorn HL, Poon JL, Davies EW, Paczkowski R, Curtis SE, Boye KS. Evaluating preferences for profiles of GLP-1 receptor agonists among injection-naive type 2 diabetes patients in the UK. Patient Prefer Adherence. 2015;9:1611–22.

4. Hixson-Wallace JA, Dotson JB, Blakey SA. Effect of regimen complexity on patient satisfaction and compliance with warfarin therapy. Clin Appl Thromb Hemost. 2001;7(1):33–7.

5. Matza LS, Boye KS, Currie BM, et al. Patient perceptions of injection devices used with dulaglutide and liraglutide for treatment of type 2 diabetes. Curr Med Res Opin. 2018;34(8):1457–64.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physician Perceptions of Dose Escalation for Type 2 Diabetes Medications in the United States;Diabetes Therapy;2023-11-18

2. Disutility of injectable therapies in obesity and type 2 diabetes mellitus: general population preferences in the UK, Canada, and China;The European Journal of Health Economics;2022-05-08

3. Evaluating the Impact of Therapy on Quality of Life in Type 2 Diabetes: A Literature Review of Utilities Associated with Treatment-Related Attributes;Patient Related Outcome Measures;2022-05

4. Vignette-Based Utilities: Usefulness, Limitations, and Methodological Recommendations;Value in Health;2021-06